Поиск
Закладки
Озвучить текст Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.
Чрезмерная рвота беременных

Список литературы

  1. Brown H.L. Nausea and vomiting of pregnancy. Contemp Ob Gyn. 2016; 61(4):48–50.
  2. Kramer J., Bowen A., Stewart N., Muhajarine N. Nausea and Vomiting of Pregnancy. MCN Am J Matern Nurs. 2013; 38(1):21–7.
  3. Miller F. Nausea and vomiting in pregnancy: The problem of perception - Is it really a disease? Am J Obstet Gynecol. 2002; 186(5):182–3.
  4. Buckwalter J.G., Simpson S.W. Psychological factors in the etiology and treatment of severe nausea and vomiting in pregnancy. Am J Obstet Gynecol. 2002; 186(5 Suppl Understanding):S210-4.
  5. O’Brien B. USE OF INDIGENOUS EXPLANATIONS AND REMEDIES TO FURTHER UNDERSTAND NAUSEA AND VOMITING DURING PREGNANCY. Health Care Women Int. 1999; 20(1):49–61.
  6. Kimura M., Amino N., Tamaki H., Ito E., Mitsuda N., Miyai K., et al. Gestational thyrotoxicosis and hyperemesis gravidarum: possible role of hCG with higher stimulating activity. Clin Endocrinol (Oxf). 1993; 38(4):345–50.
  7. Goodwin T.M., Montoro M., Mestman J.H., Pekary A.E., Hershman J.M. The role of chorionic gonadotropin in transient hyperthyroidism of hyperemesis gravidarum. J Clin Endocrinol Metab. 1992; 75(5):1333–7.
  8. Sorah K., Alderson T.L. Hyperthyroidism In Pregnancy. StatPearls. 2021.
  9. Depue R.H., Bernstein L., Ross R.K., Judd H.L., Henderson B.E. Hyperemesis gravidarum in relation to estradiol levels, pregnancy outcome, and other maternal factors: a seroepidemiologic study. Am J Obstet Gynecol. 1987; 156(5):1137–41.
  10. Brzana R.J., Koch K.L. Gastroesophageal reflux disease presenting with intractable nausea. Ann Intern Med. 1997; 126(9):704–7.
  11. Fejzo M.S., Sazonova O. V, Sathirapongsasuti J.F., Hallgrímsdóttir I.B., Vacic V., MacGibbon K.W., et al. Placenta and appetite genes GDF15 and IGFBP7 are associated with hyperemesis gravidarum. Nat Commun. 2018; 9(1):1178.
  12. Innes A.M., Seargeant L.E., Balachandra K., Roe C.R., Wanders R.J., Ruiter J.P., et al. Hepatic carnitine palmitoyltransferase I deficiency presenting as maternal illness in pregnancy. Pediatr Res. 2000; 47(1):43–5.
  13. Rodien P., Brémont C., Sanson M.L., Parma J., Van Sande J., Costagliola S., et al. Familial gestational hyperthyroidism caused by a mutant thyrotropin receptor hypersensitive to human chorionic gonadotropin. N Engl J Med. 1998; 339(25):1823–6.
  14. Hayakawa S., Nakajima N., Karasaki-Suzuki M., Yoshinaga H., Arakawa Y., Satoh K., et al. FREQUENT PRESENCE OF HELICOBACTER PYLORI GENOME IN THE SALIVA OF PATIENTS WITH HYPEREMESIS GRAVIDARUM. Am J Perinatol. 2000; Volume 17(Number 05):243–8.
  15. Einarson T.R., Piwko C., Koren G. Quantifying the global rates of nausea and vomiting of pregnancy: a meta analysis. J Popul Ther Clin Pharmacol = J la Ther des Popul la Pharmacol Clin. 2013; 20(2):e171-83.
  16. Matthews A., Dowswell T., Haas D.M., Doyle M., O’Mathúna D.P. Interventions for nausea and vomiting in early pregnancy. Cochrane database Syst Rev. 2010; (9):CD007575.
  17. Goodwin T.M. Hyperemesis gravidarum. Obstet Gynecol Clin North Am. 2008; 35(3):401–17, viii.
  18. Trogstad L.I.S., Stoltenberg C., Magnus P., Skjaerven R., Irgens L.M. Recurrence risk in hyperemesis gravidarum. BJOG. 2005; 112(12):1641–5.
  19. Fejzo M.S., Macgibbon K.W., Romero R., Goodwin T.M., Mullin P.M. Recurrence risk of hyperemesis gravidarum. J Midwifery Womens Health. 56(2):132–6.
  20. Gadsby R., Barnie-Adshead A.M., Jagger C. A prospective study of nausea and vomiting during pregnancy. Br J Gen Pract. 1993; 43(371):245–8.
  21. Mitchell-Jones N., Gallos I., Farren J., Tobias A., Bottomley C., Bourne T. Psychological morbidity associated with hyperemesis gravidarum: a systematic review and meta-analysis. BJOG. 2017; 124(1):20–30.
  22. Ezberci İ., Güven E.S.G., Ustüner I., Sahin F.K., Hocaoğlu C. Disability and psychiatric symptoms in hyperemesis gravidarum patients. Arch Gynecol Obstet. 2014; 289(1):55–60.
  23. Walch A., Duke M., Auty T., Wong A. Profound Hypokalaemia Resulting in Maternal Cardiac Arrest: A Catastrophic Complication of Hyperemesis Gravidarum? Case Rep Obstet Gynecol. 2018; 2018:4687587.
  24. Debby A., Golan A., Sadan O., Glezerman M., Shirin H. Clinical utility of esophagogastroduodenoscopy in the management of recurrent and intractable vomiting in pregnancy. J Reprod Med. 2008; 53(5):347–51.
  25. Gill S.K., O’Brien L., Einarson T.R., Koren G. The safety of proton pump inhibitors (PPIs) in pregnancy: a meta-analysis. Am J Gastroenterol. 2009; 104(6):1541–5; quiz 1540, 1546.
  26. Eroğlu A., Kürkçüoğlu C., Karaoğlanoğlu N., Tekinbaş C., Cesur M. Spontaneous esophageal rupture following severe vomiting in pregnancy. Dis esophagus  Off J Int Soc Dis Esophagus. 2002; 15(3):242–3.
  27. Liang S.-G., Ooka F., Santo A., Kaibara M. Pneumomediastinum following esophageal rupture associated with hyperemesis gravidarum. J Obstet Gynaecol Res. 2002; 28(3):172–5.
  28. Nguyen N., Deitel M., Lacy E. Splenic avulsion in a pregnant patient with vomiting. Can J Surg. 1995; 38(5):464–5.
  29. Garg R., Sanjay, Das V., Usman K., Rungta S., Prasad R. Spontaneous pneumothorax: an unusual complication of pregnancy--a case report and review of literature. Ann Thorac Med. 2008; 3(3):104–5.
  30. Goodwin T.M., Montoro M., Mestman J.H. Transient hyperthyroidism and hyperemesis gravidarum: clinical aspects. Am J Obstet Gynecol. 1992; 167(3):648–52.
  31. Vandraas K.F., Vikanes A. V, Vangen S., Magnus P., Støer N.C., Grjibovski A.M. Hyperemesis gravidarum and birth outcomes-a population-based cohort study of 2.2 million births in the Norwegian Birth Registry. BJOG. 2013; 120(13):1654–60.
  32. Chin R.K., Lao T.T. Low birth weight and hyperemesis gravidarum. Eur J Obstet Gynecol Reprod Biol. 1988; 28(3):179–83.
  33. Weigel M.M., Weigel R.M. Nausea and vomiting of early pregnancy and pregnancy outcome. An epidemiological study. Br J Obstet Gynaecol. 1989; 96(11):1304–11.
  34. Veenendaal M.V.E., van Abeelen A.F.M., Painter R.C., van der Post J.A.M., Roseboom T.J. Consequences of hyperemesis gravidarum for offspring: a systematic review and meta-analysis. BJOG. 2011; 118(11):1302–13.
  35. Rotman P., Hassin D., Mouallem M., Barkai G., Farfel Z. Wernicke’s encephalopathy in hyperemesis gravidarum: association with abnormal liver function. Isr J Med Sci. 1994; 30(3):225–8.
  36. Koch K.L. Gastrointestinal factors in nausea and vomiting of pregnancy. Am J Obstet Gynecol. 2002; 186(5 Suppl Understanding):S198-203.
  37. Einion A. The management of nausea and vomiting of pregnancy and hyperemesis gravidarum. Pract Midwife. 2016; 19(9):33–5.
  38. Niemeijer M.N., Grooten I.J., Vos N., Bais J.M.J., van der Post J.A., Mol B.W., et al. Diagnostic markers for hyperemesis gravidarum: a systematic review and metaanalysis. Am J Obstet Gynecol. 2014; 211(2):150.e1-15.
  39. Jarvis S., Nelson-Piercy C. Management of nausea and vomiting in pregnancy. BMJ. 2011; 342(jun17 1):d3606–d3606.
  40. Tran T.T., Ahn J., Reau N.S. ACG Clinical Guideline: Liver Disease and Pregnancy. Am J Gastroenterol. 2016; 111(2):176–94.
  41. Jennings L.K., Mahdy H. Hyperemesis Gravidarum [Internet]. StatPearls. 2022.
  42. Jueckstock J.K., Kaestner R., Mylonas I. Managing hyperemesis gravidarum: a multimodal challenge. BMC Med. 2010; 8:46.
  43. Li L., Li L., Zhou X., Xiao S., Gu H., Zhang G. Helicobacter pylori Infection Is Associated with an Increased Risk of Hyperemesis Gravidarum: A Meta-Analysis. Gastroenterol Res Pract. 2015; 2015:278905.
  44. Magtira A., Schoenberg F.P., MacGibbon K., Tabsh K., Fejzo M.S. Psychiatric factors do not affect recurrence risk of hyperemesis gravidarum. J Obstet Gynaecol Res. 2015; 41(4):512–6.
  45. McCormack D., Scott-Heyes G., McCusker C.G. The impact of hyperemesis gravidarum on maternal mental health and maternal-fetal attachment. J Psychosom Obstet Gynaecol. 2011; 32(2):79–87.
  46. Loveland Cook C.A., Flick L.H., Homan S.M., Campbell C., McSweeney M., Gallagher M.E. Posttraumatic stress disorder in pregnancy: prevalence, risk factors, and treatment. Obstet Gynecol. 2004; 103(4):710–7.
  47. Christodoulou-Smith J., Gold J.I., Romero R., Goodwin T.M., Macgibbon K.W., Mullin P.M., et al. Posttraumatic stress symptoms following pregnancy complicated by hyperemesis gravidarum. J Matern Fetal Neonatal Med. 2011; 24(11):1307–11.
  48. Mazzotta P., Stewart D.E., Koren G., Magee L.A. Factors associated with elective termination of pregnancy among Canadian and American women with nausea and vomiting of pregnancy. J Psychosom Obstet Gynaecol. 2001; 22(1):7–12.
  49. Davis M. Nausea and vomiting of pregnancy: an evidence-based review. J Perinat Neonatal Nurs. 18(4):312–28.
  50. Quinla J.D., Hill D.A. Nausea and vomiting of pregnancy. Am Fam Physician. 2003; 68(1):121–8.
  51. Koren G., Maltepe C. Pre-emptive therapy for severe nausea and vomiting of pregnancy and hyperemesis gravidarum. J Obstet Gynaecol. 2004; 24(5):530–3.
  52. Maltepe C., Koren G. Preemptive treatment of nausea and vomiting of pregnancy: results of a randomized controlled trial. Obstet Gynecol Int. 2013; 2013:809787.
  53. Wegrzyniak L.J., Repke J.T., Ural S.H. Treatment of hyperemesis gravidarum. Rev Obstet Gynecol. 2012; 5(2):78–84.
  54. Dante G., Pedrielli G., Annessi E., Facchinetti F. Herb remedies during pregnancy: a systematic review of controlled clinical trials. J Matern Fetal Neonatal Med. 2013; 26(3):306–12.
  55. Thomson M., Corbin R., Leung L. Effects of ginger for nausea and vomiting in early pregnancy: a meta-analysis. J Am Board Fam Med. 27(1):115–22.
  56. Ding M., Leach M., Bradley H. The effectiveness and safety of ginger for pregnancy-induced nausea and vomiting: a systematic review. Women Birth. 2013; 26(1):e26-30.
  57. Portnoi G., Chng L.-A., Karimi-Tabesh L., Koren G., Tan M.P., Einarson A., et al. Prospective comparative study of the safety and effectiveness of ginger for the treatment of nausea and vomiting in pregnancy. Am J Obstet Gynecol. 2003; 189(5):1374–7.
  58. Boone S.A., Shields K.M. Treating pregnancy-related nausea and vomiting with ginger. Ann Pharmacother. 2005; 39(10):1710–3.
  59. Basirat Z., Moghadamnia A.A., Kashifard M., Sarifi-Razavi A. The effect of ginger biscuit on nausea and vomiting in early pregnancy. Acta Med Iran. 2009; 47(1):51–6.
  60. Mazzotta P., Magee L.A. A Risk-Benefit Assessment of Pharmacological and Nonpharmacological Treatments for Nausea and Vomiting of Pregnancy. Drugs. 2000; 59(4):781–800.
  61. Erick M., Cox J.T., Mogensen K.M. ACOG Practice Bulletin 189: Nausea and Vomiting of Pregnancy. Obstet Gynecol. 2018; 131(5):935.
  62. Tan A., Foran T., Henry A. Managing nausea and vomiting in pregnancy in a primary care setting. Aust Fam Physician. 2016; 45(8):564–8.
  63. Sahakian V., Rouse D., Sipes S., Rose N., Niebyl J. Vitamin B6 is effective therapy for nausea and vomiting of pregnancy: a randomized, double-blind placebo-controlled study. Obstet Gynecol. 1991; 78(1):33–6.
  64. Pope E., Maltepe C., Koren G. Comparing pyridoxine and doxylamine succinate-pyridoxine HCl for nausea and vomiting of pregnancy: A matched, controlled cohort study. J Clin Pharmacol. 2015; 55(7):809–14.
  65. McKeigue P.M., Lamm S.H., Linn S., Kutcher J.S. Bendectin and birth defects: I. A meta-analysis of the epidemiologic studies. Teratology. 1994; 50(1):27–37.
  66. Kutcher J.S., Engle A., Firth J., Lamm S.H. Bendectin and birth defects. II: Ecological analyses. Birth Defects Res A Clin Mol Teratol. 2003; 67(2):88–97.
  67. Madjunkova S., Maltepe C., Koren G. The delayed-release combination of doxylamine and pyridoxine (Diclegis®/Diclectin ®) for the treatment of nausea and vomiting of pregnancy. Paediatr Drugs. 2014; 16(3):199–211.
  68. Magee L.A., Mazzotta P., Koren G. Evidence-based view of safety and effectiveness of pharmacologic therapy for nausea and vomiting of pregnancy (NVP). Am J Obstet Gynecol. 2002; 186(5 Suppl Understanding):S256-61.
  69. Gilboa S.M., Ailes E.C., Rai R.P., Anderson J.A., Honein M.A. Antihistamines and birth defects: a systematic review of the literature. Expert Opin Drug Saf. 2014; 13(12):1667–98.
  70. Bustos M., Venkataramanan R., Caritis S. Nausea and vomiting of pregnancy - What’s new? Auton Neurosci. 2017; 202:62–72.
  71. Koren G., Clark S., Hankins G.D. V, Caritis S.N., Umans J.G., Miodovnik M., et al. Maternal safety of the delayed-release doxylamine and pyridoxine combination for nausea and vomiting of pregnancy; a randomized placebo controlled trial. BMC Pregnancy Childbirth. 2015; 15:59.
  72. Gill S.K., Einarson A. The safety of drugs for the treatment of nausea and vomiting of pregnancy. Expert Opin Drug Saf. 2007; 6(6):685–94.
  73. Pasternak B., Svanström H., Mølgaard-Nielsen D., Melbye M., Hviid A. Metoclopramide in Pregnancy and Risk of Major Congenital Malformations and Fetal Death. JAMA. 2013; 310(15):1601.
  74. Chiossi G., Neri I., Cavazzuti M., Basso G., Facchinetti F. Hyperemesis gravidarum complicated by Wernicke encephalopathy: background, case report, and review of the literature. Obstet Gynecol Surv. 2006; 61(4):255–68.
  75. Di Gangi S., Gizzo S., Patrelli T.S., Saccardi C., D’Antona D., Nardelli G.B. Wernicke’s encephalopathy complicating hyperemesis gravidarum: from the background to the present. J Matern Fetal Neonatal Med. 2012; 25(8):1499–504.
  76. Anderka M., Mitchell A.A., Louik C., Werler M.M., Hernández-Diaz S., Rasmussen S.A., et al. Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects. Birth Defects Res A Clin Mol Teratol. 2012; 94(1):22–30.
  77. Danielsson B., Wikner B.N., Källén B. Use of ondansetron during pregnancy and congenital malformations in the infant. Reprod Toxicol. 2014; 50:134–7.
  78. Carstairs S.D. Ondansetron Use in Pregnancy and Birth Defects: A Systematic Review. Obstet Gynecol. 2016; 127(5):878–83.
  79. Taylor R. Successful management of hyperemesis gravidarum using steroid therapy. QJM. 1996; 89(2):103–7.
  80. Togay-Işikay C., Yiğit A., Mutluer N. Wernicke’s encephalopathy due to hyperemesis gravidarum: an under-recognised condition. Aust N Z J Obstet Gynaecol. 2001; 41(4):453–6.
  81. Kim Y., Lee S., Rah S., Lee J. Wernicke’s encephalopathy in hyperemesis gravidarum. Can J Ophthalmol. 2002; 37(1):37–8.
  82. European Medicines Agency. European Medicines Agency recommends changes to the use of metoclopramide Changes aim mainly to reduce the risk of neurological side effects. 2014; 44(December 2013):1–5.
  83. Abas M.N., Tan P.C., Azmi N., Omar S.Z. Ondansetron compared with metoclopramide for hyperemesis gravidarum: a randomized controlled trial. Obstet Gynecol. 2014; 123(6):1272–9.
  84. Mitchell A.A., Gilboa S.M., Werler M.M., Kelley K.E., Louik C., Hernández-Díaz S., et al. Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008. Am J Obstet Gynecol. 2011; 205(1):51.e1-8.
  85. Pasternak B., Svanström H., Hviid A. Ondansetron in pregnancy and risk of adverse fetal outcomes. N Engl J Med. 2013; 368(9):814–23.
  86. Kashifard M., Basirat Z., Kashifard M., Golsorkhtabar-Amiri M., Moghaddamnia A. Ondansetrone or metoclopromide? Which is more effective in severe nausea and vomiting of pregnancy? A randomized trial double-blind study. Clin Exp Obstet Gynecol. 2013; 40(1):127–30.
  87. Oliveira L.G., Capp S.M., You W.B., Riffenburgh R.H., Carstairs S.D. Ondansetron compared with doxylamine and pyridoxine for treatment of nausea in pregnancy: a randomized controlled trial. Obstet Gynecol. 2014; 124(4):735–42.
  88. Nelson-Piercy C., Fayers P., de Swiet M. Randomised, double-blind, placebo-controlled trial of corticosteroids for the treatment of hyperemesis gravidarum. BJOG. 2001; 108(1):9–15.
  89. Safari H.R., Fassett M.J., Souter I.C., Alsulyman O.M., Goodwin T.M. The efficacy of methylprednisolone in the treatment of hyperemesis gravidarum: a randomized, double-blind, controlled study. Am J Obstet Gynecol. 1998; 179(4):921–4.
  90. Bondok R.S., El Sharnouby N.M., Eid H.E., Abd Elmaksoud A.M. Pulsed steroid therapy is an effective treatment for intractable hyperemesis gravidarum. Crit Care Med. 2006; 34(11):2781–3.
  91. Carmichael S.L., Shaw G.M. Maternal corticosteroid use and risk of selected congenital anomalies. Am J Med Genet. 1999; 86(3):242–4.
  92. Rodríguez-Pinilla E., Martínez-Frías M.L. Corticosteroids during pregnancy and oral clefts: a case-control study. Teratology. 1998; 58(1):2–5.
  93. Popa S.L., Barsan M., Caziuc A., Pop C., Muresan L., Popa L.C., et al. Life-threatening complications of hyperemesis gravidarum. Exp Ther Med. 2021; 21(6):642.
  94. Sanghvi U., Thankappan K.R., Sarma P.S., Sali N. Assessing potential risk factors for child malnutrition in rural Kerala, India. J Trop Pediatr. 2001; 47(6):350–5.
  95. Thrombosis and Embolism during Pregnancy and the Puerperium, Reducing the Risk. Green-top Guidel. 2015; No. 37a.
  96. Tan P.C., Khine P.P., Vallikkannu N., Omar S.Z. Promethazine compared with metoclopramide for hyperemesis gravidarum: a randomized controlled trial. Obstet Gynecol. 2010; 115(5):975–81.
  97. Rumeau-Rouquette C., Goujard J., Huel G. Possible teratogenic effect of phenothiazines in human beings. Teratology. 1977; 15(1):57–64.
  98. NICE. Intravenous fluid therapy in adults in hospital. Natl Inst Clin Excell. 2013; (December):1–37.
  99. Bergin P.S., Harvey P. Wernicke’s encephalopathy and central pontine myelinolysis associated with hyperemesis gravidarum. BMJ. 1992; 305(6852):517–8.
  100. Greenspoon J.S., Masaki D.I., Kurz C.R. Cardiac tamponade in pregnancy during central hyperalimentation. Obstet Gynecol. 1989; 73(3 Pt 2):465–6.
  101. Ogura J.M., Francois K.E., Perlow J.H., Elliott J.P. Complications associated with peripherally inserted central catheter use during pregnancy. Am J Obstet Gynecol. 2003; 188(5):1223–5.
  102. Cape A. V, Mogensen K.M., Robinson M.K., Carusi D.A. Peripherally inserted central catheter (PICC) complications during pregnancy. JPEN J Parenter Enteral Nutr. 2014; 38(5):595–601.
  103. Tan P.C., Omar S.Z. Contemporary approaches to hyperemesis during pregnancy. Curr Opin Obstet Gynecol. 2011; 23(2):87–93.
  104. Stokke G., Gjelsvik B.L., Flaatten K.T., Birkeland E., Flaatten H., Trovik J. Hyperemesis gravidarum, nutritional treatment by nasogastric tube feeding: a 10-year retrospective cohort study. Acta Obstet Gynecol Scand. 2015; 94(4):359–67.
  105. Holmgren C., Aagaard-Tillery K.M., Silver R.M., Porter T.F., Varner M. Hyperemesis in pregnancy: an evaluation of treatment strategies with maternal and neonatal outcomes. Am J Obstet Gynecol. 2008; 198(1):56.e1-4.
  106. Hsu J.J., Clark-Glena R., Nelson D.K., Kim C.H. Nasogastric enteral feeding in the management of hyperemesis gravidarum. Obstet Gynecol. 1996; 88(3):343–6.
  107. Saha S., Loranger D., Pricolo V., Degli-Esposti S. Feeding jejunostomy for the treatment of severe hyperemesis gravidarum: a case series. JPEN J Parenter Enteral Nutr. 33(5):529–34.
  108. Vaisman N., Kaidar R., Levin I., Lessing J.B. Nasojejunal feeding in hyperemesis gravidarum--a preliminary study. Clin Nutr. 2004; 23(1):53–7.
  109. Russo-Stieglitz K.E., Levine A.B., Wagner B.A., Armenti V.T. Pregnancy outcome in patients requiring parenteral nutrition. J Matern Fetal Med. 8(4):164–7.
  110. Zibell-Frisk D., Jen K.L., Rick J. Use of parenteral nutrition to maintain adequate nutritional status in hyperemesis gravidarum. J Perinatol. 1990; 10(4):390–5.
  111. Folk J.J., Leslie-Brown H.F.M., Nosovitch J.T., Silverman R.K., Aubry R.H. Hyperemesis gravidarum: outcomes and complications with and without total parenteral nutrition. J Reprod Med. 2004; 49(7):497–502.
  112. Peled Y., Melamed N., Hiersch L., Pardo J., Wiznitzer A., Yogev Y. The impact of total parenteral nutrition support on pregnancy outcome in women with hyperemesis gravidarum. J Matern Fetal Neonatal Med. 2014; 27(11):1146–50.
  113. McParlin C., O’Donnell A., Robson S.C., Beyer F., Moloney E., Bryant A., et al. Treatments for Hyperemesis Gravidarum and Nausea and Vomiting in Pregnancy: A Systematic Review. JAMA. 2016; 316(13):1392–401.
  114. Roscoe J.A., Matteson S.E. Acupressure and acustimulation bands for control of nausea: a brief review. Am J Obstet Gynecol. 2002; 186(5 Suppl Understanding):S244-7.
  115. Smith C., Crowther C., Beilby J. Pregnancy outcome following women’s participation in a randomised controlled trial of acupuncture to treat nausea and vomiting in early pregnancy. Complement Ther Med. 2002; 10(2):78–83.
  116. Lee E.J., Frazier S.K. The efficacy of acupressure for symptom management: a systematic review. J Pain Symptom Manage. 2011; 42(4):589–603.
  117. Madrid A., Giovannoli R., Wolfe M. Treating persistent nausea of pregnancy with hypnosis: four cases. Am J Clin Hypn. 2011; 54(2):107–15.
  118. Czeizel A.E., Dudas I., Fritz G., Técsöi A., Hanck A., Kunovits G. The effect of periconceptional multivitamin-mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Arch Gynecol Obstet. 1992; 251(4):181–5.
  119. Emelianova S., Mazzotta P., Einarson A., Koren G. Prevalence and severity of nausea and vomiting of pregnancy and effect of vitamin supplementation. Clin Invest Med. 1999; 22(3):106–10.
  120. Magee L.A., Chandra K., Mazzotta P., Stewart D., Koren G., Guyatt G.H. Development of a health-related quality of life instrument for nausea and vomiting of pregnancy. Am J Obstet Gynecol. 2002; 186(5 Suppl Understanding):S232-8.
  121. Power Z., Thomson A.M., Waterman H. Understanding the stigma of hyperemesis gravidarum: qualitative findings from an action research study. Birth. 2010; 37(3):237–44.
  122. McCarthy F.P., Murphy A., Khashan A.S., McElroy B., Spillane N., Marchocki Z., et al. Day care compared with inpatient management of nausea and vomiting of pregnancy: a randomized controlled trial. Obstet Gynecol. 2014; 124(4):743–8.
  123. McParlin C., Carrick-Sen D., Steen I.N., Robson S.C. Hyperemesis in Pregnancy Study: a pilot randomised controlled trial of midwife-led outpatient care. Eur J Obstet Gynecol Reprod Biol. 2016; 200:6–10.
  124. Godsey R.K., Newman R.B. Hyperemesis gravidarum. A comparison of single and multiple admissions. J Reprod Med. 1991; 36(4):287–90.
  125. Hinkle S.N., Mumford S.L., Grantz K.L., Silver R.M., Mitchell E.M., Sjaarda L.A., et al. Association of Nausea and Vomiting During Pregnancy With Pregnancy Loss: A Secondary Analysis of a Randomized Clinical Trial. JAMA Intern Med. 2016; 176(11):1621–7.
  126. Dodds L., Fell D.B., Joseph K.S., Allen V.M., Butler B. Outcomes of pregnancies complicated by hyperemesis gravidarum. Obstet Gynecol. 2006; 107(2 Pt 1):285–92.
  127. Al-Ozairi E., Waugh J.J.S., Taylor R. Termination is not the treatment of choice for severe hyperemesis gravidarum: Successful management using prednisolone. Obstet Med. 2009; 2(1):34–7.
  128. Poursharif B., Korst L.M., Macgibbon K.W., Fejzo M.S., Romero R., Goodwin T.M. Elective pregnancy termination in a large cohort of women with hyperemesis gravidarum. Contraception. 2007; 76(6):451–5.
  129. Mazzota P., Magee L., Koren G. Therapeutic abortions due to severe morning sickness. Unacceptable combination. Can Fam Physician. 1997; 43:1055–7.
  130. Whitehead S.A., Andrews P.L.R., Chamberlain G.V.P. Characterisation of nausea and vomiting in early pregnancy: a survey of 1000 women. J Obstet Gynaecol (Lahore). 1992; 12(6):364–9.
  131. Basso O., Olsen J. Sex Ratio and Twinning in Women With Hyperemesis or Pre-eclampsia. Epidemiology. 2001; 12(6):747–9.
  132. Nelson‐Piercy C. et al. The Management of Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum (Green‐top Guideline No. 69) //BJOG: An International Journal of Obstetrics & Gynaecology. – 2024.
  133. Joshi A, Chadha G, Narayanan P. From Discomfort to Distress: A Critical Analysis of Hyperemesis Gravidarum in the Emergency Room. Cureus. 2023 Aug 23;15(8):e44004. doi: 10.7759/cureus.44004. PMID: 37746494; PMCID: PMC10516742.
  134. Ashraf V. V. et al. Wernicke"s encephalopathy due to hyperemesis gravidarum: Clinical and magnetic resonance imaging characteristics //Journal of postgraduate medicine. – 2016. – Т. 62. – №. 4. – С. 260-263.
  135. Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin No. 189: Nausea And Vomiting Of Pregnancy. Obstet Gynecol. 2018 Jan;131(1):e15-e30. doi: 10.1097/AOG.0000000000002456. PMID: 29266076.
  136. Huybrechts KF, Hernández-Díaz S, Straub L, Gray KJ, Zhu Y, Patorno E, Desai RJ, Mogun H, Bateman BT. Association of Maternal First-Trimester Ondansetron Use With Cardiac Malformations and Oral Clefts in Offspring. JAMA. 2018 Dec 18;320(23):2429-2437. doi: 10.1001/jama.2018.18307. PMID: 30561479; PMCID: PMC6669077..
  137. Oliveira LG, Capp SM, You WB, Riffenburgh RH, Carstairs SD. Ondansetron compared with doxylamine and pyridoxine for treatment of nausea in pregnancy: a randomized controlled trial. Obstet Gynecol. 2014 Oct;124(4):735-742. doi: 10.1097/AOG.0000000000000479. PMID: 25198265.
  138. Reducing the Risk of Venous Thromboembolism during Pregnancy and the Puerperium. Green-top Guideline No. 37a April 2015
  139. Tan PC, Norazilah MJ, Omar SZ. Dextrose saline compared with normal saline rehydration of hyperemesis gravidarum: a randomized controlled trial. Obstet Gynecol. 2013 Feb;121(2 Pt 1):291-298. doi: 10.1097/AOG.0b013e31827c5e99. PMID: 23232754
  140. Nelson-Piercy C, Dean C, Shehmar M, Gadsby R, O’Hara M, Hodson K, et al; the Royal College of Obstetricians and Gynaecologists. The Management of Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum (Green-top Guideline No. 69). BJOG. 2024; 131(7): e1–e30.
  141. Viktoriya London, Stephanie Grube, David M. Sherer, Ovadia Abulafia; Hyperemesis Gravidarum: A Review of Recent Literature. Pharmacology 3 August 2017; 100 (3-4): 161–171. https://doi.org/10.1159/000477853
  142. Loh KY, Sivalingam N. Understanding hyperemesis gravidarum. Med J Malaysia. 2005 Aug;60(3):394-9; quiz 400. PMID: 16379204.

Для продолжения работы требуется Registration
На предыдущую страницу

Предыдущая страница

Следующая страница

На следующую страницу
Список литературы
На предыдущую главу Предыдущая глава
оглавление
Следующая глава На следующую главу

Table of contents

Данный блок поддерживает скрол*